Metabolic Reprogramming and Ferroptosis: Unlocking New Therapeutic Frontiers in Cancer and Diabetes
Recently developed technologies such as CRISPR-based functional genomics, metabolomics, and AI-powered modeling represent new-age tools in defining ferroptosis networks and precision therapeutics design. Integration of the regulation of normal physiological ferroptosis into cancer and diabetes therapy has the potential to redefine redox-targeted therapy and metabolic medicine. <i>Antioxid. Redox Signal.</i> 00, 000-000.
Authors
- Z. Li
- Fangpei Ma (ORCID: https://orcid.org/0000-0002-2222-2531)
- Qiuyi Zhang (ORCID: https://orcid.org/0000-0002-9278-2649)
- Yu Zhao
- Yaoxiong Xia
- Zhun Gu
- Nannan Zhang
- Danyu Zhu
- Yan Huo
- Yanjie Li
- Yanping Gao
Institutions
- Target (United States) (US)
- Kunming Medical University (CN)
- Henan Cancer Hospital (CN)
- Suzhou Chien-Shiung Institute of Technology (CN)
Publication Details
- Journal
- Antioxidants and Redox Signaling
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1177/15230864261421487
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00